Factors of interest
neuropathy
NEUROPATHY
We accessed patient factors including age at baseline, sex, height and weight at baseline (which we used to calculate BMI), baseline neuropathy, and chemotherapy regimen. Two chemotherapy regimens were allowed in SCOT—fluorouracil with oxaliplatin (FOLFOX) or capecitabine with oxaliplatin (CAPOX). The regimen was decided by clinicians before randomisation. The dose of oxaliplatin in FOLFOX was 85 mg/m